Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.43 |
| ▸ | CCR6 | P51684 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11790891 | 0.98 | ALDH1A1 (0.48) | ALDH1A1MAPTHPGDTDP1MAPK1 | |
| SCHEMBL10915717 | 0.92 | LMNA (0.47) | ALDH1A1MAPTHPGDTDP1MAPK1 | |
| SCHEMBL1270807 | 0.92 | LMNA (0.51) | ALDH1A1MAPTHPGDTDP1MAPK1 | |
| SCHEMBL8165909 | 0.90 | FABP7 (0.45) | ALDH1A1MAPTHPGDCHRM2CHRM5 | |
| SCHEMBL5967396 | 0.90 | KEAP1 (0.47) | ALDH1A1MAPTHPGDTDP1MAPK1 | |
| SCHEMBL8905179 | 0.90 | ALDH1A1 (0.47) | ALDH1A1MAPTHPGDTDP1MAPK1 | |
| SCHEMBL7350797 | 0.87 | ALDH1A1 (0.49) | ALDH1A1MAPTHPGDTDP1MAPK1 | |
| SCHEMBL9686344 | 0.87 | CHRM1 (0.52) | KMT2ACHRM2CHRM5CHRM1CHRM3 | |
| SCHEMBL5967202 | 0.87 | KEAP1 (0.51) | ALDH1A1MAPTHPGDCHRM5CHRM1 | |
| Potassium Ion SCHEMBL11790895 | 0.86 | ALDH1A1 (0.49) | ALDH1A1MAPTHPGDTDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118085016-B | Preparation method of D-phenylglycinyl-glycine | 天津卡普希科技有限公司 | 2024-07-30 | — | — | CN | claimed |
| CN-118085016-A | Preparation method of D-phenylglycinyl-glycine | 天津卡普希科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-105367510-A | Method for preparing (2R,4S)-3-Cbz-2,4-diphenyl-1,3-oxazolidine-5-ketone | YE HAIWEI | 2016-03-02 | — | — | CN | claimed |
| CN-105152959-A | Synthesis method of (2S, 3S)-3-amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride | SHANGHAI SYNTHEALL PHARMACEUTICAL CO LTD | 2015-12-16 | — | — | CN | claimed |
| EP-0950046-B1 | 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS | NAEJA PHARMACEUTICAL INC (CA) | 2002-04-10 | — | — | EP | claimed |
| EP-0950046-A1 | 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS | SYNPHAR LABORATORIES INC. (CA) | 1999-10-20 | — | — | EP | claimed |
| WO-1998012176-A1 | 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS | SYNPHAR LABORATORIES INC. (US) | 1998-03-26 | — | — | WO | claimed |
| US-20260137677-A1 | PROTACS USEFUL AGAINST THE MAIN PROTEASE SARS-COV-2 | TOCRIS COOKSON LTD (GB) | 2026-05-21 | — | — | US | disclosed |
| EP-4598914-A1 | PROTACS USEFUL AGAINST THE MAIN PROTEASE SARS-COV-2 | Tocris Cookson Limited (GB) | 2025-08-13 | — | — | EP | disclosed |
| US-20240399776-A1 | COLOR DEVELOPER, THERMAL RECORDING MATERIAL, AND THERMAL RECORDING LAYER COATING MATERIAL | SANKO CO., LTD. (JP) | 2024-12-05 | — | — | US | disclosed |
| CN-118085016-B | Preparation method of D-phenylglycinyl-glycine | 天津卡普希科技有限公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-118085016-B | Preparation method of D-phenylglycinyl-glycine | 天津卡普希科技有限公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-118085016-A | Preparation method of D-phenylglycinyl-glycine | 天津卡普希科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-4068080-A | BETA-LACTAM ANTIBIOTICS, CEPHALOSPORIN ANALOGS | BRISTOL-MYERS COMPANY (US) | 1978-01-10 | — | — | US | disclosed |
| US-4068075-A | ANTIBIOTICS | BRISTOL-MYERS COMPANY (US) | 1978-01-10 | — | — | US | disclosed |
| US-4066831-A | ANTIBIOTICS | BRISTOL-MYERS COMPANY (US) | 1978-01-03 | — | — | US | disclosed |
| US-4066832-A | ANTIBIOTICS | BRISTOL-MYERS COMPANY (US) | 1978-01-03 | — | — | US | disclosed |
| US-4065623-A | O-2-Isocephem-4-carboxylic acid derivatives as antibacterial agents | BRISTOL-MYERS COMPANY (US) | 1977-12-27 | — | — | US | disclosed |
| US-4012383-A | BACTERICIDES | BRISTOL-MYERS COMPANY (US) | 1977-03-15 | — | — | US | disclosed |
| US-4011216-A | Δ2,3-0-2-Isocephem-4-carboxylic acid and derivatives thereof as antibacterial agents | BRISTOL-MYERS COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137677-A1 | PROTACS USEFUL AGAINST THE MAIN PROTEASE SARS-COV-2 | XIAP, MDM2, SARS1 | ALDH1A1 4410/4885MAPT 898/4885HPGD 4644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.